1. Home
  2. MLYS vs CCNE Comparison

MLYS vs CCNE Comparison

Compare MLYS & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$23.96

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$28.23

Market Cap

818.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
CCNE
Founded
2019
1865
Country
United States
United States
Employees
N/A
950
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
818.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MLYS
CCNE
Price
$23.96
$28.23
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$48.67
$32.00
AVG Volume (30 Days)
1.1M
121.3K
Earning Date
03-12-2026
04-13-2026
Dividend Yield
N/A
2.62%
EPS Growth
37.43
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$23.21
Revenue Next Year
N/A
$7.00
P/E Ratio
N/A
$11.84
Revenue Growth
N/A
N/A
52 Week Low
$10.44
$19.32
52 Week High
$47.65
$30.84

Technical Indicators

Market Signals
Indicator
MLYS
CCNE
Relative Strength Index (RSI) 32.42 53.37
Support Level $13.42 $23.52
Resistance Level $31.09 $28.32
Average True Range (ATR) 1.75 0.80
MACD -0.24 0.00
Stochastic Oscillator 15.31 77.41

Price Performance

Historical Comparison
MLYS
CCNE

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About CCNE CNB Financial Corporation

CNB Financial Corp is a Pennsylvania-chartered bank. The bank is a full-service bank engaging in a full range of banking activities and services for individual, business, governmental and institutional customers. These activities and services principally include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and a variety of other specialized financial services. Its Private Client Solutions division offers a full range of client services, including private banking and wealth and asset management. The banking segment derives its revenue through the operations as a full-service bank services, including trust and wealth management services, for individual, business, governmental, and institutional customers.

Share on Social Networks: